Wahafu Alafate
Guangzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
GPRC5A modulates resistance to temozolomide in glioblastoma through glycolytic reprogramming.
Journal: International journal of biological macromolecules
Published: May 03, 2025
A nomogram for predicting the diagnosis of central malignant tumors based on preoperative clinical characteristics and laboratory indicators: a diagnostic study.
Journal: International journal of surgery (London, England)
Published: April 08, 2025
Case Report: Intracranial ectopic schwannoma originating from the internal carotid artery wall.
Journal: Frontiers in surgery
Published: August 03, 2024
Targeting ARNT attenuates chemoresistance through destabilizing p38α-MAPK signaling in glioblastoma.
Targeting ARNT attenuates chemoresistance through destabilizing p38α-MAPK signaling in glioblastoma.
Journal: Cell death & disease
Published: January 06, 2024
The Efficacy and Safety of Intraoperative Radiotherapy in the Treatment of Recurrent High-Grade Glioma: A Single-Center Prospective Study.
Journal: World neurosurgery
Published: January 13, 2023
NEK2 enhances malignancies of glioblastoma via NIK/NF-κB pathway.
Journal: Cell death & disease
Published: August 16, 2021
Loss of PLK2 induces acquired resistance to temozolomide in GBM via activation of notch signaling.
Journal: Journal of experimental & clinical cancer research : CR
Published: June 10, 2020
Preoperative Prediction Nomogram Based on Integrated Profiling for Glioblastoma Multiforme in Glioma Patients.
Journal: Frontiers in oncology
Published: April 27, 2020
Elevation of CXCL1 indicates poor prognosis and radioresistance by inducing mesenchymal transition in glioblastoma.
Journal: CNS neuroscience & therapeutics
Published: August 16, 2019
Targeting Aurora kinase B attenuates chemoresistance in glioblastoma via a synergistic manner with temozolomide.
Journal: Pathology, research and practice
Published: June 21, 2019
Combined elevation of AURKB and UBE2C predicts severe outcomes and therapy resistance in glioma.
Journal: Pathology, research and practice
Published: June 02, 2019
Showing 1-11 of 11
Last Updated: 09/26/2026